Skip to main content

Cynosure Group, LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1763409 Salt Lake City, UT

Position in PTGX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$488,528
New position
Shares Held
4,635
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 57% Shared 43% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cynosure Group, LLC holds $3,204,499 across 4 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $488,528 4,635